{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-152946","form_type":"8-K","ticker":"PHAT","cik":"0001783183","company_name":"Phathom Pharmaceuticals, Inc.","filed_at":"2023-05-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.548600+00:00","generated_at":"2026-06-14T16:07:16.441758+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Phathom prices public offering of 11.125M shares at $11.75/share for ~$130.7M gross","bullets":["Offering of 11,125,000 shares at $11.75/share; gross proceeds ~$130.7M.","Underwriters have 30-day option to purchase up to 1,668,750 additional shares.","Net proceeds ~$122.4M ($140.8M if option exercised) to fund vonoprazan clinical dev., pre-commercial, and working capital.","Offering expected to close May 26, 2023; Jefferies and Evercore ISI act as joint bookrunners."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-152946","json":"https://secwatch.observer/filing/0001193125-23-152946.json","markdown":"https://secwatch.observer/filing/0001193125-23-152946.md","text":"https://secwatch.observer/filing/0001193125-23-152946.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1783183/000119312523152946/0001193125-23-152946-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1783183/000119312523152946/d452618d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T16:07:16.441758+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}